mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway

H Kato1, S Nakajima, Y Saito

  • 1Department of Molecular Signaling, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Yamanashi 409-3898, Japan.

Insights

Rapamycin, an inhibitor of mTOR complex 1 (mTORC1), reduces cell death caused by endoplasmic reticulum (ER) stress. This occurs by blocking the IRE1-JNK pathway, protecting cells from ER stress-induced apoptosis.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mammalian target of rapamycin (mTOR) regulates critical cellular functions.
  • Endoplasmic reticulum (ER) stress triggers apoptosis through the unfolded protein response (UPR).

Purpose of the Study:

  • To investigate the role of mTOR complex 1 (mTORC1) in ER stress-induced apoptosis.
  • To determine the specific UPR pathways affected by mTORC1 inhibition.

Main Methods:

  • Utilized rapamycin, an mTORC1 inhibitor, to study its effects on ER stress.
  • Examined the impact on IRE1-JNK, PERK, and ATF6 pathways.
  • Assessed Akt phosphorylation and JNK activity in vitro and in vivo models.

Main Results:

  • Rapamycin selectively suppressed the IRE1-JNK pathway, not PERK or ATF6.
  • ER stress induced mTORC1 activation, leading to IRE1-JNK activation and apoptosis.
  • mTORC1 activation reduced Akt phosphorylation, preceding IRE1-JNK signaling and apoptosis.
  • In vivo, rapamycin reduced renal tubular injury and apoptosis in mice.

Conclusions:

  • mTORC1 activation under ER stress promotes apoptosis via Akt suppression and IRE1-JNK pathway induction.
  • Targeting mTORC1 may offer a therapeutic strategy for conditions involving ER stress-induced apoptosis.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...